141 related articles for article (PubMed ID: 12539559)
1. Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization.
Yi J; Liao X; Yang Z; Li X
J Tongji Med Univ; 2001; 21(4):321-2, 331. PubMed ID: 12539559
[TBL] [Abstract][Full Text] [Related]
2. Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells.
Xiao EH; Guo D; Bian DJ
World J Gastroenterol; 2009 Sep; 15(36):4582-6. PubMed ID: 19777619
[TBL] [Abstract][Full Text] [Related]
3. Endostatin inhibits angiogenesis in hepatocellular carcinoma after transarterial chemoembolization.
Bao Y; Feng WM; Tang CW; Zheng YY; Gong HB; Hou EG
Hepatogastroenterology; 2012; 59(117):1566-8. PubMed ID: 22456329
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
Zuo CH; Xia M; Liu JS; Qiu XX; Lei X; Xu RC; Liu HC; Li JL; Li YG; Li QL; Xiao H; Hong Y; Wang XH; Zhu HZ; Wu QF; Burns M; Liu C
Asian Pac J Cancer Prev; 2015; 16(1):245-51. PubMed ID: 25640360
[TBL] [Abstract][Full Text] [Related]
5. Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization.
Liao X; Yi J; Li X; Yang Z; Deng W; Tian G
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(3):280-2. PubMed ID: 14526434
[TBL] [Abstract][Full Text] [Related]
6. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
[TBL] [Abstract][Full Text] [Related]
7. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
8. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.
Wang B; Xu H; Gao ZQ; Ning HF; Sun YQ; Cao GW
Acta Radiol; 2008 Jun; 49(5):523-9. PubMed ID: 18568538
[TBL] [Abstract][Full Text] [Related]
11. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion.
Zou Y; Guo CG; Zhang MM
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4751-61. PubMed ID: 26744866
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of bile duct injury after transcatheter arterial chemoembolization].
Wang MQ; Shao RH; Ye HY; Wang ZQ; Wang ZP; Liu FY
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):609-12. PubMed ID: 16438871
[TBL] [Abstract][Full Text] [Related]
14. [A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-up].
Haruno M; Shimamura R; Ogawa Y; Tanaka H; Sakai K; Araki K
Gan To Kagaku Ryoho; 2005 May; 32(5):667-70. PubMed ID: 15918569
[TBL] [Abstract][Full Text] [Related]
15. Tumour ablation and hepatic decompensation rates in multi-agent chemoembolization of hepatocellular carcinoma.
Shah SR; Riordan SM; Karani J; Williams R
QJM; 1998 Dec; 91(12):821-8. PubMed ID: 10024947
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and therapy for primary hepatic carcinoma: transcatheter inferior phrenic arteriography and chemoembolization.
Xu HB; Yan XQ
J Tongji Med Univ; 1993; 13(3):186-9. PubMed ID: 8295270
[TBL] [Abstract][Full Text] [Related]
18. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
Murakami T; Ishimaru H; Sakamoto I; Uetani M; Matsuoka Y; Daikoku M; Honda S; Koshiishi T; Fujimoto T
Cardiovasc Intervent Radiol; 2007; 30(4):696-704. PubMed ID: 17497071
[TBL] [Abstract][Full Text] [Related]
20. [A case of successful treatment by interferon-α and 5-fluorouracil combination therapy (FAIT) and transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus].
Kishimoto T; Wada H; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2484-6. PubMed ID: 22202421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]